COMPARISON OF INDIRECT IMMUNOFLUORESCENCE AND MEMBRANE FLUORESCENCE ASSAYS FOR THE DIFFERENTIATION OF ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2

被引:3
|
作者
GALLO, D [1 ]
HOFFMAN, MN [1 ]
YEH, ET [1 ]
GEORGE, JR [1 ]
HANSON, CV [1 ]
机构
[1] CTR DIS CONTROL,DIV HIV AIDS,LAB INVEST BRANCH,ATLANTA,GA 30333
关键词
D O I
10.1128/JCM.30.9.2275-2278.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Serum samples from 20 human immunodeficiency virus type 1 (HIV-1)- and 30 HIV-2-infected and 7 dually infected individuals were reacted by using the indirect immunofluorescence assay (IFA) and membrane fluorescence assay in order to determine whether these methods were useful for typing HIV-1 and HIV-2 antibodies. Although 41 of 50 (82%) of the HIV-1- and HIV-2-positive specimens cross-reacted to some extent with the heterologous antigen in the IFA, the antigen with the higher titer correlated completely with the infecting type. The IFA could not distinguish single from dual infections, however. In contrast, only 4 of the 50 (8%) serum samples cross-reacted in the membrane fluorescence test. All seven of the specimens from patients with mixed infections reacted with both antigens. The membrane fluorescence test appears to be reliable for serodifferentiation of HIV-1 and HIV-2 infections and may be useful for laboratories with low-volume typing requirements.
引用
收藏
页码:2275 / 2278
页数:4
相关论文
共 50 条
  • [1] A NEWLY DEVELOPED IMMUNOFLUORESCENCE ASSAY FOR SIMULTANEOUS DETECTION OF ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    TANABETOCHIKURA, A
    SINGH, MTA
    TSUCHIE, H
    ZHANG, J
    PALADIN, FJE
    KURIMURA, T
    JOURNAL OF VIROLOGICAL METHODS, 1995, 52 (03) : 239 - 246
  • [2] COMPARISON OF VERTICAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMISSION IN THE FRENCH PROSPECTIVE COHORT
    COURPOTIN, C
    SIMON, F
    MATHERON, S
    FIRTION, G
    DECREPY, A
    CIRARUVIGNERON, N
    MAZI, F
    FLOCH, C
    MEIER, F
    TALON, P
    MEYOHAS, MC
    DANDINE, M
    HERVE, F
    DIMARIA, H
    MEHARZIE, X
    ALLEMON, C
    NOSEDA, G
    VIAL, M
    DELFRAISSY, JF
    CHAMBRIN, V
    RETALI, B
    MOUCHINO, F
    HELLER, C
    PASCAL, C
    VINAS, A
    LACHASSINE, E
    JEANTILS, V
    WIPFF, P
    BOTTO, C
    BLANCHE, S
    VEBER, F
    BURGARD, M
    TERRIS, J
    ROUZIOUX, C
    GRISCELLI, C
    BRUNNER, C
    SEGUY, X
    DOUARD, D
    FLEURY, H
    MICHEL, G
    TAMALET, C
    DOUSSIN, A
    MOUDOUB, Y
    LAURENT, C
    MAYAUX, MJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (06) : 502 - 506
  • [3] A NOVEL ENZYME-IMMUNOASSAY FOR ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS, TYPE-1 AND TYPE-2
    FREELEY, P
    WONG, P
    WHITELEY, G
    CONTE, K
    DRAYLYONS, K
    DESPLAINES, K
    METZMANN, E
    CLINICAL CHEMISTRY, 1990, 36 (06) : 1091 - 1091
  • [4] THE SPECIFICITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 TRANSACTIVATOR IS DIFFERENT FROM THAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    EMERMAN, M
    GUYADER, M
    MONTAGNIER, L
    BALTIMORE, D
    MUESING, MA
    EMBO JOURNAL, 1987, 6 (12): : 3755 - 3760
  • [5] IMMUNOPRECIPITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 GLYCOPROTEINS BY SERA POSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ESPEJO, RT
    URIBE, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (09) : 2107 - 2110
  • [6] SYNTHETIC PEPTIDE ASSAYS TO DETECT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 IN SEROPOSITIVE INDIVIDUALS
    SMITH, RS
    PARKS, DE
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1990, 114 (03) : 254 - 258
  • [7] PREVALENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 INFECTIONS IN NIGERIA
    OLALEYE, OD
    BERNSTEIN, L
    EKWEOZOR, CC
    SHENG, ZJ
    OMILABU, SA
    LI, XY
    SULLIVANHALLEY, J
    RASHEED, S
    JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03): : 710 - 714
  • [8] INFECTION OF NONLYMPHOID CELLS BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 OR TYPE-2
    IKEUCHI, K
    KIM, S
    BYRN, RA
    GOLDRING, SR
    GROOPMAN, JE
    JOURNAL OF VIROLOGY, 1990, 64 (09) : 4226 - 4231
  • [9] ACQUIRED IMMUNODEFICIENCY WITHOUT EVIDENCE OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    LAURENCE, J
    SIEGAL, FP
    SCHATTNER, E
    GELMAN, IH
    MORSE, S
    LANCET, 1992, 340 (8814): : 273 - 274
  • [10] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ANTIGEN AND CULTURE ASSAYS
    JACKSON, JB
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1990, 114 (03) : 249 - 253